
Meningitis? (Anti-myelin oligodendrocyte glycoprotein immunoglobulin G antibodyrelated disease) A clinical analysis
Publication year - 2022
Language(s) - English
DOI - 10.33140/mcr.07.04.01
Subject(s) - medicine , myelin oligodendrocyte glycoprotein , immunology , antibody , encephalitis , autoimmune encephalitis , adjuvant , pediatrics , autoantibody , multiple sclerosis , virus , experimental autoimmune encephalomyelitis
Objective: By analyzing meningitis? (Anti-myelin oligodendrocyte glycoprotein immunoglobulin G antibody-related diseases) clinical diagnosis and treatment methods to improve clinicians’ understanding of autoimmune encephalitis. Methods: Collect 1 case of meningitis? (Anti-myelin oligodendrocyte glycoprotein immunoglobulin G antibody-related disease) patient’s clinical data, combined with literature review, to analyze the diagnosis and treatment methods of this case. Results: The patient, male, 26 years old, was admitted to the hospital mainly because of “headache for 12 days and convulsions once”. After imaging examination, hematology examination, body fluid examination, and repeated confirmation of the clinical treatment plan through remote consultation, hormones, immunosuppressants, immunoglobulins, anti-inflammatory and anti-viral treatments were given. He was discharged from the hospital and re-examined 2 months later. His condition became stable and his indicators improved. Conclusion: For patients with autoimmune encephalitis, in addition to actively doing antibody detection and adjuvant therapy, it is necessary to adhere to the treatment plan mainly focusing on the treatment of autoimmune encephalitis, and do not focus too much on the relevant antibody indicators, so as to avoid deviations in the formulation of treatment plans, resulting in The condition fluctuates, and the patient’s condition persists.